SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION vs prolaio eVO2peak Module

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

by DIACOUSTIC MEDICAL DEVICES (PTY)

prolaio eVO2peak Module

by Prolaio

AI Verdict

While both are FDA-cleared AI tools categorized under Cardiology AI and Clinical Decision Support, they address distinct clinical needs. Tool A focuses on diagnosing heart murmurs by analyzing acoustic heart signals from an electronic stethoscope. In contrast, Tool B estimates peak oxygen consumption using data from wearable sensors for cardiovascular research and care, making them adjacent rather than direct competitors.

Choose SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION if…

Choose SENSICARDIAC MOBI if you need an immediate, AI-powered diagnostic aid at the point of care to differentiate between physiological and pathological heart murmurs during a physical examination. This tool is ideal for physicians using an electronic stethoscope to quickly assess acoustic heart signals and inform initial diagnostic decisions.

View SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION →

Choose prolaio eVO2peak Module if…

Choose prolaio eVO2peak Module if you require longitudinal assessment of a patient's cardiovascular fitness and functional capacity using real-world data from wearable sensors. This module is best suited for tracking peak oxygen consumption over time, aiding in cardiovascular research, rehabilitation, or sports medicine evaluations where understanding changes in eVO2peak is crucial for patient management.

View prolaio eVO2peak Module →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION	prolaio eVO2peak Module
Pricing	Contact for pricing	Contact for pricing
Deployment	Hosted server environment (Linux OS) with a mobile application interface	Cloud-based (software-only, processes remote sensor data)
BAA Available	Yes AI-estimated	Yes AI-estimated
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

Tool A, SensiCardiac Mobi, is designed as a mobile application for physicians to directly capture and analyze heart sounds during an examination, with reported improvements in usability and positive user scores. This direct, interactive workflow at the point of care offers clear usability for diagnostic tasks. Tool B, Prolaio eVO2peak Module, involves a patient-facing app for data collection from wearables and a separate clinician workbench, which is a different user paradigm.

Clinical Value

Tie

Both tools offer significant and distinct clinical value. Tool A directly aids in diagnosing heart murmurs by differentiating physiological from pathological sounds, potentially reducing unnecessary referrals. Tool B provides an estimated peak oxygen consumption (eVO2peak) from real-world data, a critical metric for cardiovascular research and care, with documented clinical validation for accuracy and reliability. Their value is high in different, yet complementary, aspects of cardiology.

Pricing & Value

Tie

Both SensiCardiac Mobi and Prolaio eVO2peak Module require direct contact for pricing, and no public pricing details are available in the provided facts or through web searches. Without transparent pricing or detailed cost-benefit analyses, it is impossible to conduct a head-to-head comparison of their value propositions.

Enterprise Readiness

prolaio eVO2peak Module

Both tools are FDA-cleared, HIPAA compliant, and offer Business Associate Agreements (BAAs), demonstrating a strong foundation for enterprise use. However, Tool B's cloud-based, software-only deployment model generally offers greater scalability, easier integration, and reduced on-premise IT burden compared to Tool A's hosted server environment, which might require more client-side infrastructure management.

Innovation

prolaio eVO2peak Module

While both tools leverage AI for clinical decision support, Tool B demonstrates greater innovation by utilizing a locked deep-learning model to estimate eVO2peak from high-density, longitudinal data collected via qualified third-party FDA-cleared wearable medical sensors. This approach represents a forward-thinking application of real-world data and remote patient monitoring for complex physiological assessment and cardiovascular research.

Support & Docs

prolaio eVO2peak Module

Tool B, Prolaio, has a visible 'Help Center' powered by Zendesk and explicitly mentions providing technical support for its devices and studies. In contrast, specific support pages or documentation for Tool A, SensiCardiac Mobi, were not readily found through web searches or detailed in the provided facts, suggesting a less transparent or accessible support infrastructure.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION	prolaio eVO2peak Module
Name	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION	prolaio eVO2peak Module
Company	DIACOUSTIC MEDICAL DEVICES (PTY)	Prolaio
Primary Function	Assists physicians in diagnosing heart murmurs by analyzing acoustic heart signals to differentiate between physiological and pathological sounds.	Estimates peak oxygen consumption (eVO2peak) using real-world patient data for cardiovascular research and care.
Key Inputs/Data Used	Acoustic heart signals from a compatible electronic stethoscope (user-provided)	Demographic data, single-lead ECG, and triaxial accelerometry inputs from qualified third-party FDA-cleared wearable medical sensors
Key Output/Functionality	Distinguishes between normal/physiological and pathological heart murmurs; identifies S1, S2, and suspected murmurs.	Estimates peak oxygen consumption (eVO2peak); provides information as an adjunctive aid in clinical evaluation.
Specialties	Cardiology, Internal Medicine, Pediatrics	Cardiology, Physical Medicine & Rehab, Sports Medicine

Videos

Demos, reviews, and walkthroughs featuring SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION and prolaio eVO2peak Module.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate with existing EHR systems and clinical workflows to minimize disruption and maximize data utility?

SensiCardiac Mobi, a mobile application, captures heart sound data during auscultation, which would then need a defined pathway for integration into the EHR, potentially through manual entry or a specific interface. Prolaio eVO2peak Module processes remote sensor data to estimate eVO2peak, requiring established data feeds from third-party wearables and a mechanism to push this derived information into the EHR for clinical review.

What specific data or studies can you provide regarding the accuracy and sensitivity of the diagnostic algorithms for heart murmur differentiation (Tool A) and eVO2peak estimation (Tool B)?

SensiCardiac Mobi utilizes the Sensi Diagnostic Heart Murmur Algorithm to distinguish between physiological and pathological heart murmurs and identify S1, S2, and suspected murmurs; the company would need to provide specific performance metrics or clinical validation studies for this algorithm. Prolaio eVO2peak Module applies a locked deep-learning model to estimate peak oxygen consumption using demographic data, single-lead ECG, and triaxial accelerometry, and clinical validation was performed using data from patients undergoing cardiopulmonary exercise tests (CPET) in a multi-center study.

Beyond the listed specialties, in which specific clinical scenarios or patient populations would each tool provide the most significant clinical value?

SensiCardiac Mobi could be highly valuable in primary care for initial heart murmur screening, potentially reducing unnecessary referrals, or in pediatric cardiology for early detection. Prolaio eVO2peak Module could offer significant value in managing patients with heart failure for longitudinal monitoring of functional capacity, in pre-operative risk stratification, or for guiding rehabilitation programs in patients recovering from cardiac events.

What is the typical learning curve for physicians and their staff to effectively utilize each tool, and what is the estimated time-to-value for seeing clinical benefits?

The learning curve for SensiCardiac Mobi primarily involves familiarization with its mobile application interface and proper electronic stethoscope technique, suggesting a relatively quick integration into existing physical exam workflows. For Prolaio eVO2peak Module, the learning curve would involve understanding the data inputs from wearable sensors and interpreting eVO2peak estimations, with clinical value realized once data streams are established and integrated into care pathways.

What are the key considerations and support mechanisms for implementing and scaling these solutions across multiple clinical sites or a large healthcare system?

For SensiCardiac Mobi, multi-site rollout would necessitate managing electronic stethoscope distribution, ensuring consistent mobile application deployment, and providing training across sites, with centralized support for the hosted server environment. Prolaio eVO2peak Module's cloud-based nature simplifies multi-site deployment, focusing on integrating with various third-party wearable sensors and establishing secure data pipelines, with scalable training and technical support for data interpretation and integration being crucial.